Cagrilintide/semaglutide
A Research Study to See How Well CagriSema Compared to Tirzepatide Helps People With Obesity Lose Weight
Novo Nordisk · Phase 3 · Completed · Enrollment 809
| Arm | Population | Dose | Weeks | Estimand | Weight change |
|---|---|---|---|---|---|
| CagriSema 2.4 mg/2.4 mg | Obesity or overweight | 2.4 mg | 16 | n/r | n/r |
| Tirzepatide 15 mg | Obesity or overweight | 15 mg | 16 | n/r | n/r |